Tzield and Type 1

A physician discusses the potential of Tzield, a newly FDA-approved treatment, and its implications for halting the progression of type 1 diabetes. The conversation takes a personal turn as experiences with childhood illnesses, like hand, foot, and mouth disease, are shared, highlighting the emotional journey of navigating diabetes diagnosis and treatment.